Global Meningococcal Vaccine Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 542464
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: Life Sciences
|
Format : 
The global Meningococcal Vaccine market was valued at 230.87 Million USD in 2020 and will grow with a CAGR of 4.33% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
By Market Verdors:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
By Types:
Quadrivalent
Bivalent
By Applications:
Pneumonia
Meningitis
Bacteremia
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
By Market Verdors:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
By Types:
Quadrivalent
Bivalent
By Applications:
Pneumonia
Meningitis
Bacteremia
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Meningococcal Vaccine Market Size Analysis from 2022 to 2027
1.5.1 Global Meningococcal Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Meningococcal Vaccine Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Meningococcal Vaccine Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Meningococcal Vaccine Industry Impact
Chapter 2 Global Meningococcal Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Meningococcal Vaccine (Volume and Value) by Type
2.1.1 Global Meningococcal Vaccine Consumption and Market Share by Type (2016-2021)
2.1.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2016-2021)
2.2 Global Meningococcal Vaccine (Volume and Value) by Application
2.2.1 Global Meningococcal Vaccine Consumption and Market Share by Application (2016-2021)
2.2.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2016-2021)
2.3 Global Meningococcal Vaccine (Volume and Value) by Regions
2.3.1 Global Meningococcal Vaccine Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Meningococcal Vaccine Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Meningococcal Vaccine Consumption by Regions (2016-2021)
4.2 North America Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.10 South America Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Meningococcal Vaccine Market Analysis
5.1 North America Meningococcal Vaccine Consumption and Value Analysis
5.1.1 North America Meningococcal Vaccine Market Under COVID-19
5.2 North America Meningococcal Vaccine Consumption Volume by Types
5.3 North America Meningococcal Vaccine Consumption Structure by Application
5.4 North America Meningococcal Vaccine Consumption by Top Countries
5.4.1 United States Meningococcal Vaccine Consumption Volume from 2016 to 2021
5.4.2 Canada Meningococcal Vaccine Consumption Volume from 2016 to 2021
5.4.3 Mexico Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 6 East Asia Meningococcal Vaccine Market Analysis
6.1 East Asia Meningococcal Vaccine Consumption and Value Analysis
6.1.1 East Asia Meningococcal Vaccine Market Under COVID-19
6.2 East Asia Meningococcal Vaccine Consumption Volume by Types
6.3 East Asia Meningococcal Vaccine Consumption Structure by Application
6.4 East Asia Meningococcal Vaccine Consumption by Top Countries
6.4.1 China Meningococcal Vaccine Consumption Volume from 2016 to 2021
6.4.2 Japan Meningococcal Vaccine Consumption Volume from 2016 to 2021
6.4.3 South Korea Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 7 Europe Meningococcal Vaccine Market Analysis
7.1 Europe Meningococcal Vaccine Consumption and Value Analysis
7.1.1 Europe Meningococcal Vaccine Market Under COVID-19
7.2 Europe Meningococcal Vaccine Consumption Volume by Types
7.3 Europe Meningococcal Vaccine Consumption Structure by Application
7.4 Europe Meningococcal Vaccine Consumption by Top Countries
7.4.1 Germany Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.2 UK Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.3 France Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.4 Italy Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.5 Russia Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.6 Spain Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.7 Netherlands Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.8 Switzerland Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.9 Poland Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 8 South Asia Meningococcal Vaccine Market Analysis
8.1 South Asia Meningococcal Vaccine Consumption and Value Analysis
8.1.1 South Asia Meningococcal Vaccine Market Under COVID-19
8.2 South Asia Meningococcal Vaccine Consumption Volume by Types
8.3 South Asia Meningococcal Vaccine Consumption Structure by Application
8.4 South Asia Meningococcal Vaccine Consumption by Top Countries
8.4.1 India Meningococcal Vaccine Consumption Volume from 2016 to 2021
8.4.2 Pakistan Meningococcal Vaccine Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Meningococcal Vaccine Market Analysis
9.1 Southeast Asia Meningococcal Vaccine Consumption and Value Analysis
9.1.1 Southeast Asia Meningococcal Vaccine Market Under COVID-19
9.2 Southeast Asia Meningococcal Vaccine Consumption Volume by Types
9.3 Southeast Asia Meningococcal Vaccine Consumption Structure by Application
9.4 Southeast Asia Meningococcal Vaccine Consumption by Top Countries
9.4.1 Indonesia Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.2 Thailand Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.3 Singapore Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.4 Malaysia Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.5 Philippines Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.6 Vietnam Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.7 Myanmar Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 10 Middle East Meningococcal Vaccine Market Analysis
10.1 Middle East Meningococcal Vaccine Consumption and Value Analysis
10.1.1 Middle East Meningococcal Vaccine Market Under COVID-19
10.2 Middle East Meningococcal Vaccine Consumption Volume by Types
10.3 Middle East Meningococcal Vaccine Consumption Structure by Application
10.4 Middle East Meningococcal Vaccine Consumption by Top Countries
10.4.1 Turkey Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.3 Iran Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.5 Israel Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.6 Iraq Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.7 Qatar Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.8 Kuwait Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.9 Oman Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 11 Africa Meningococcal Vaccine Market Analysis
11.1 Africa Meningococcal Vaccine Consumption and Value Analysis
11.1.1 Africa Meningococcal Vaccine Market Under COVID-19
11.2 Africa Meningococcal Vaccine Consumption Volume by Types
11.3 Africa Meningococcal Vaccine Consumption Structure by Application
11.4 Africa Meningococcal Vaccine Consumption by Top Countries
11.4.1 Nigeria Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.2 South Africa Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.3 Egypt Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.4 Algeria Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.5 Morocco Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 12 Oceania Meningococcal Vaccine Market Analysis
12.1 Oceania Meningococcal Vaccine Consumption and Value Analysis
12.2 Oceania Meningococcal Vaccine Consumption Volume by Types
12.3 Oceania Meningococcal Vaccine Consumption Structure by Application
12.4 Oceania Meningococcal Vaccine Consumption by Top Countries
12.4.1 Australia Meningococcal Vaccine Consumption Volume from 2016 to 2021
12.4.2 New Zealand Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 13 South America Meningococcal Vaccine Market Analysis
13.1 South America Meningococcal Vaccine Consumption and Value Analysis
13.1.1 South America Meningococcal Vaccine Market Under COVID-19
13.2 South America Meningococcal Vaccine Consumption Volume by Types
13.3 South America Meningococcal Vaccine Consumption Structure by Application
13.4 South America Meningococcal Vaccine Consumption Volume by Major Countries
13.4.1 Brazil Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.2 Argentina Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.3 Columbia Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.4 Chile Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.5 Venezuela Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.6 Peru Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.8 Ecuador Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Meningococcal Vaccine Business
14.1 Novartis
14.1.1 Novartis Company Profile
14.1.2 Novartis Meningococcal Vaccine Product Specification
14.1.3 Novartis Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 GSK
14.2.1 GSK Company Profile
14.2.2 GSK Meningococcal Vaccine Product Specification
14.2.3 GSK Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Merck
14.3.1 Merck Company Profile
14.3.2 Merck Meningococcal Vaccine Product Specification
14.3.3 Merck Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 CSL
14.4.1 CSL Company Profile
14.4.2 CSL Meningococcal Vaccine Product Specification
14.4.3 CSL Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Baxter
14.5.1 Baxter Company Profile
14.5.2 Baxter Meningococcal Vaccine Product Specification
14.5.3 Baxter Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 JN International Medical Corporation
14.6.1 JN International Medical Corporation Company Profile
14.6.2 JN International Medical Corporation Meningococcal Vaccine Product Specification
14.6.3 JN International Medical Corporation Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Serum Institute of India
14.7.1 Serum Institute of India Company Profile
14.7.2 Serum Institute of India Meningococcal Vaccine Product Specification
14.7.3 Serum Institute of India Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Bio-Med
14.8.1 Bio-Med Company Profile
14.8.2 Bio-Med Meningococcal Vaccine Product Specification
14.8.3 Bio-Med Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 China National Biotec Group
14.9.1 China National Biotec Group Company Profile
14.9.2 China National Biotec Group Meningococcal Vaccine Product Specification
14.9.3 China National Biotec Group Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Hualan Bio
14.10.1 Hualan Bio Company Profile
14.10.2 Hualan Bio Meningococcal Vaccine Product Specification
14.10.3 Hualan Bio Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Walvax
14.11.1 Walvax Company Profile
14.11.2 Walvax Meningococcal Vaccine Product Specification
14.11.3 Walvax Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Zhifei
14.12.1 Zhifei Company Profile
14.12.2 Zhifei Meningococcal Vaccine Product Specification
14.12.3 Zhifei Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Meningococcal Vaccine Market Forecast (2022-2027)
15.1 Global Meningococcal Vaccine Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Meningococcal Vaccine Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Meningococcal Vaccine Value and Growth Rate Forecast (2022-2027)
15.2 Global Meningococcal Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Meningococcal Vaccine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Meningococcal Vaccine Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Meningococcal Vaccine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Meningococcal Vaccine Consumption Forecast by Type (2022-2027)
15.3.2 Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027)
15.3.3 Global Meningococcal Vaccine Price Forecast by Type (2022-2027)
15.4 Global Meningococcal Vaccine Consumption Volume Forecast by Application (2022-2027)
15.5 Meningococcal Vaccine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Meningococcal Vaccine Market Size Analysis from 2022 to 2027
1.5.1 Global Meningococcal Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Meningococcal Vaccine Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Meningococcal Vaccine Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Meningococcal Vaccine Industry Impact
Chapter 2 Global Meningococcal Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Meningococcal Vaccine (Volume and Value) by Type
2.1.1 Global Meningococcal Vaccine Consumption and Market Share by Type (2016-2021)
2.1.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2016-2021)
2.2 Global Meningococcal Vaccine (Volume and Value) by Application
2.2.1 Global Meningococcal Vaccine Consumption and Market Share by Application (2016-2021)
2.2.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2016-2021)
2.3 Global Meningococcal Vaccine (Volume and Value) by Regions
2.3.1 Global Meningococcal Vaccine Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Meningococcal Vaccine Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Meningococcal Vaccine Consumption by Regions (2016-2021)
4.2 North America Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
4.10 South America Meningococcal Vaccine Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Meningococcal Vaccine Market Analysis
5.1 North America Meningococcal Vaccine Consumption and Value Analysis
5.1.1 North America Meningococcal Vaccine Market Under COVID-19
5.2 North America Meningococcal Vaccine Consumption Volume by Types
5.3 North America Meningococcal Vaccine Consumption Structure by Application
5.4 North America Meningococcal Vaccine Consumption by Top Countries
5.4.1 United States Meningococcal Vaccine Consumption Volume from 2016 to 2021
5.4.2 Canada Meningococcal Vaccine Consumption Volume from 2016 to 2021
5.4.3 Mexico Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 6 East Asia Meningococcal Vaccine Market Analysis
6.1 East Asia Meningococcal Vaccine Consumption and Value Analysis
6.1.1 East Asia Meningococcal Vaccine Market Under COVID-19
6.2 East Asia Meningococcal Vaccine Consumption Volume by Types
6.3 East Asia Meningococcal Vaccine Consumption Structure by Application
6.4 East Asia Meningococcal Vaccine Consumption by Top Countries
6.4.1 China Meningococcal Vaccine Consumption Volume from 2016 to 2021
6.4.2 Japan Meningococcal Vaccine Consumption Volume from 2016 to 2021
6.4.3 South Korea Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 7 Europe Meningococcal Vaccine Market Analysis
7.1 Europe Meningococcal Vaccine Consumption and Value Analysis
7.1.1 Europe Meningococcal Vaccine Market Under COVID-19
7.2 Europe Meningococcal Vaccine Consumption Volume by Types
7.3 Europe Meningococcal Vaccine Consumption Structure by Application
7.4 Europe Meningococcal Vaccine Consumption by Top Countries
7.4.1 Germany Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.2 UK Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.3 France Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.4 Italy Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.5 Russia Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.6 Spain Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.7 Netherlands Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.8 Switzerland Meningococcal Vaccine Consumption Volume from 2016 to 2021
7.4.9 Poland Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 8 South Asia Meningococcal Vaccine Market Analysis
8.1 South Asia Meningococcal Vaccine Consumption and Value Analysis
8.1.1 South Asia Meningococcal Vaccine Market Under COVID-19
8.2 South Asia Meningococcal Vaccine Consumption Volume by Types
8.3 South Asia Meningococcal Vaccine Consumption Structure by Application
8.4 South Asia Meningococcal Vaccine Consumption by Top Countries
8.4.1 India Meningococcal Vaccine Consumption Volume from 2016 to 2021
8.4.2 Pakistan Meningococcal Vaccine Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Meningococcal Vaccine Market Analysis
9.1 Southeast Asia Meningococcal Vaccine Consumption and Value Analysis
9.1.1 Southeast Asia Meningococcal Vaccine Market Under COVID-19
9.2 Southeast Asia Meningococcal Vaccine Consumption Volume by Types
9.3 Southeast Asia Meningococcal Vaccine Consumption Structure by Application
9.4 Southeast Asia Meningococcal Vaccine Consumption by Top Countries
9.4.1 Indonesia Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.2 Thailand Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.3 Singapore Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.4 Malaysia Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.5 Philippines Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.6 Vietnam Meningococcal Vaccine Consumption Volume from 2016 to 2021
9.4.7 Myanmar Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 10 Middle East Meningococcal Vaccine Market Analysis
10.1 Middle East Meningococcal Vaccine Consumption and Value Analysis
10.1.1 Middle East Meningococcal Vaccine Market Under COVID-19
10.2 Middle East Meningococcal Vaccine Consumption Volume by Types
10.3 Middle East Meningococcal Vaccine Consumption Structure by Application
10.4 Middle East Meningococcal Vaccine Consumption by Top Countries
10.4.1 Turkey Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.3 Iran Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.5 Israel Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.6 Iraq Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.7 Qatar Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.8 Kuwait Meningococcal Vaccine Consumption Volume from 2016 to 2021
10.4.9 Oman Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 11 Africa Meningococcal Vaccine Market Analysis
11.1 Africa Meningococcal Vaccine Consumption and Value Analysis
11.1.1 Africa Meningococcal Vaccine Market Under COVID-19
11.2 Africa Meningococcal Vaccine Consumption Volume by Types
11.3 Africa Meningococcal Vaccine Consumption Structure by Application
11.4 Africa Meningococcal Vaccine Consumption by Top Countries
11.4.1 Nigeria Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.2 South Africa Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.3 Egypt Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.4 Algeria Meningococcal Vaccine Consumption Volume from 2016 to 2021
11.4.5 Morocco Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 12 Oceania Meningococcal Vaccine Market Analysis
12.1 Oceania Meningococcal Vaccine Consumption and Value Analysis
12.2 Oceania Meningococcal Vaccine Consumption Volume by Types
12.3 Oceania Meningococcal Vaccine Consumption Structure by Application
12.4 Oceania Meningococcal Vaccine Consumption by Top Countries
12.4.1 Australia Meningococcal Vaccine Consumption Volume from 2016 to 2021
12.4.2 New Zealand Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 13 South America Meningococcal Vaccine Market Analysis
13.1 South America Meningococcal Vaccine Consumption and Value Analysis
13.1.1 South America Meningococcal Vaccine Market Under COVID-19
13.2 South America Meningococcal Vaccine Consumption Volume by Types
13.3 South America Meningococcal Vaccine Consumption Structure by Application
13.4 South America Meningococcal Vaccine Consumption Volume by Major Countries
13.4.1 Brazil Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.2 Argentina Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.3 Columbia Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.4 Chile Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.5 Venezuela Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.6 Peru Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Meningococcal Vaccine Consumption Volume from 2016 to 2021
13.4.8 Ecuador Meningococcal Vaccine Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Meningococcal Vaccine Business
14.1 Novartis
14.1.1 Novartis Company Profile
14.1.2 Novartis Meningococcal Vaccine Product Specification
14.1.3 Novartis Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 GSK
14.2.1 GSK Company Profile
14.2.2 GSK Meningococcal Vaccine Product Specification
14.2.3 GSK Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Merck
14.3.1 Merck Company Profile
14.3.2 Merck Meningococcal Vaccine Product Specification
14.3.3 Merck Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 CSL
14.4.1 CSL Company Profile
14.4.2 CSL Meningococcal Vaccine Product Specification
14.4.3 CSL Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Baxter
14.5.1 Baxter Company Profile
14.5.2 Baxter Meningococcal Vaccine Product Specification
14.5.3 Baxter Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 JN International Medical Corporation
14.6.1 JN International Medical Corporation Company Profile
14.6.2 JN International Medical Corporation Meningococcal Vaccine Product Specification
14.6.3 JN International Medical Corporation Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Serum Institute of India
14.7.1 Serum Institute of India Company Profile
14.7.2 Serum Institute of India Meningococcal Vaccine Product Specification
14.7.3 Serum Institute of India Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Bio-Med
14.8.1 Bio-Med Company Profile
14.8.2 Bio-Med Meningococcal Vaccine Product Specification
14.8.3 Bio-Med Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 China National Biotec Group
14.9.1 China National Biotec Group Company Profile
14.9.2 China National Biotec Group Meningococcal Vaccine Product Specification
14.9.3 China National Biotec Group Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Hualan Bio
14.10.1 Hualan Bio Company Profile
14.10.2 Hualan Bio Meningococcal Vaccine Product Specification
14.10.3 Hualan Bio Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Walvax
14.11.1 Walvax Company Profile
14.11.2 Walvax Meningococcal Vaccine Product Specification
14.11.3 Walvax Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Zhifei
14.12.1 Zhifei Company Profile
14.12.2 Zhifei Meningococcal Vaccine Product Specification
14.12.3 Zhifei Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Meningococcal Vaccine Market Forecast (2022-2027)
15.1 Global Meningococcal Vaccine Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Meningococcal Vaccine Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Meningococcal Vaccine Value and Growth Rate Forecast (2022-2027)
15.2 Global Meningococcal Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Meningococcal Vaccine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Meningococcal Vaccine Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Meningococcal Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Meningococcal Vaccine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Meningococcal Vaccine Consumption Forecast by Type (2022-2027)
15.3.2 Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027)
15.3.3 Global Meningococcal Vaccine Price Forecast by Type (2022-2027)
15.4 Global Meningococcal Vaccine Consumption Volume Forecast by Application (2022-2027)
15.5 Meningococcal Vaccine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Meningococcal Vaccine Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
